Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy

doi:10.3748/wjg.v20.i24.7675

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 24

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7248)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

517

WORD

253

HTML

4654

Figures (1-2)

232

Tables (1-4)

242

Sum=5898

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

766

Download

583

Sum=1349

Jun 28, 2014 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 28, 2014; 20(24): 7675-7685
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7675

Open in New Tab Full Size Figure Download Figure

Figure 1 Role of treatment intensity and the degree of immunosuppression in hepatitis B virus reactivation during cancer therapy. The risk of hepatitis B virus (HBV) reactivation is proportionate to treatment intensity and the degree of immunosuppression.

Open in New Tab Full Size Figure Download Figure

Figure 2 Risk factors of hepatitis B virus reactivation in chronic hepatitis B virus carriers with or without hepatocellular carcinoma. Modified from Jang et al[8]. ALT: Alanine aminotransferase; RT: Radiotherapy; TACE: Transarterial chemoembolization; OP: Operation; LAT: Local ablation therapy; HSCT: Hematopoietic stem cell transplantation.

Citation: Jang JW. Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy. World J Gastroenterol 2014; 20(24): 7675-7685
URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7675.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7675